These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1826873)

  • 1. [High-dose reduced glutathione in the therapy of alcoholic hepatopathy].
    Nardi EA; Devito R; Tiburzi F; Ceccanti M
    Clin Ter; 1991 Jan; 136(1):47-51. PubMed ID: 1826873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of reduced glutathione in alcoholic hepatopathy].
    Bresci G; Piccinocchi M; Banti S
    Minerva Med; 1991 Nov; 82(11):753-5. PubMed ID: 1766577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
    Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
    Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of domestic glutathione on the alcoholic liver disease].
    Zhang Q; Guo S; Hu D; He N; Zhang J; Zhong S; Chen Y; Zhang D
    Zhonghua Gan Zang Bing Za Zhi; 2000 Aug; 8(4):239-40. PubMed ID: 10951629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glutathione in the treatment of chronic fatty liver diseases].
    Dentico P; Volpe A; Buongiorno R; Grattagliano I; Altomare E; Tantimonaco G; Scotto G; Sacco R; Schiraldi O
    Recenti Prog Med; 1995; 86(7-8):290-3. PubMed ID: 7569285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alcoholic hepatopathy in psychiatric alcoholism. Clinico-statistical study].
    Mayeron MA; Ambrosoli C; Armocida G; Finavera L; Quisi Q
    Minerva Psichiatr; 1980; 21(2):155-62. PubMed ID: 7392887
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum malondialdehyde and mitochondrial aspartate aminotransferase activity as markers of chronic alcohol intake and alcoholic liver disease.
    Baldi E; Burra P; Plebani M; Salvagnini M
    Ital J Gastroenterol; 1993 Oct; 25(8):429-32. PubMed ID: 8286777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A controlled clinical study on the efficacy and tolerability of stepronin in chronic alcoholic liver diseases].
    De Rensis L; Schianchi L; Assunto A; Antenora G; Allocca F; Bossone V
    Clin Ter; 1990 Nov; 135(3):209-13. PubMed ID: 2150022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Enhancement of antioxidant capability of cancer patients during chemotherapy by reduced glutathione].
    Zhu BD; Li X; Zhao QC; Huang XL
    Ai Zheng; 2004 Apr; 23(4):452-5. PubMed ID: 15087038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metadoxine in alcohol-related pathology].
    Santoni S; Corradini P; Zocchi M; Camarri F
    Clin Ter; 1989 Jul; 130(2):115-22. PubMed ID: 2529084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Controlled clinical trial in the treatment of chronic hepatopathy of toxico-metabolic etiology].
    Carrara G; Fiocchi G; Sotti A; Dieci MG; Fiorani F; Galvani V
    Clin Ter; 1984 Jun; 109(6):545-55. PubMed ID: 6236945
    [No Abstract]   [Full Text] [Related]  

  • 12. [Value of routine biochemical investigations for detection of liver injury in alcoholics during abstinence].
    Laskus T; Lupa E; Poplewska M; Babiuch L
    Wiad Lek; 1990 Nov 1-15; 43(21-22):1027-32. PubMed ID: 2082576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic viral infection in patients with alcoholic liver involvement].
    Nikitin IG; Storozhakov GI; Volynkina VM; Uskov IuI; Kisliakov VA; Shilo VIu
    Ter Arkh; 1998; 70(2):40-4. PubMed ID: 9551570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Uridine diphosphate glucose (UDPG) in the treatment of hepatic disease from chronic alcohol abuse].
    Tarantino G; Morelli L; Califano C
    Riv Eur Sci Med Farmacol; 1990 Apr; 12(2):109-17. PubMed ID: 2080308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical efficacy of ademetionine "Heptor" in the therapy of alcohol-dependent liver disease].
    Tkachenko EI; Uspenskiĭ IuP; Skvortsova TE
    Eksp Klin Gastroenterol; 2008; (2):106-12. PubMed ID: 19145875
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of lecithin activity by vitamin-B complex to treat long term consumption of ethanol induced oxidative stress in liver.
    Das SK; Vasudevan DM
    Indian J Exp Biol; 2006 Oct; 44(10):791-801. PubMed ID: 17131909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, enzymological and histological changes in chronic diffuse liver diseases following (+)-cyanidanol-3 (Catergen) treatment.
    Halmy L; Dávid K; Nagy I; Stotz G; Kelemen JT
    Acta Physiol Hung; 1984; 64(3-4):461-70. PubMed ID: 6152370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethanol-induced dysfunction of hepatocytes and leukocytes in patients without liver failure.
    Gheorghiu M; Bâră C; Păsărică D; Braşoveanu L; Bleotu C; Topârceanu F; Trandafir T; Diaconu CC
    Roum Arch Microbiol Immunol; 2004; 63(1-2):5-33. PubMed ID: 16295318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma-glutamyltranspeptidase, aspartate aminotransferase, and erythrocyte mean corpuscular volume as indicators of alcohol consumption in liver disease.
    Eriksen J; Olsen PS; Thomsen AC
    Scand J Gastroenterol; 1984 Sep; 19(6):813-9. PubMed ID: 6151242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic glutathione deficiency in chronic hepatitis C: quantitative evaluation in patients who are HIV positive and HIV negative and correlations with plasmatic and lymphocytic concentrations and with the activity of the liver disease.
    Barbaro G; Di Lorenzo G; Soldini M; Parrotto S; Bellomo G; Belloni G; Grisorio B; Barbarini G
    Am J Gastroenterol; 1996 Dec; 91(12):2569-73. PubMed ID: 8946988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.